title: Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease.
abstract: Despite decades of intensive investigations, the precise sequence of molecular events and the specific proteins mediating the degenerative process underlying Parkinson's disease (PD) remain unraveled. Proteomic strategies may provide unbiased tools to identify novel candidates and explore original mechanisms involved in PD. Substantia nigra pars compacta (SN) tissue, whose degeneration is the hallmark of PD, was dissected from neuropathologically confirmed PD patients (n=3) and control subjects (n=3), before being submitted to a comparative 2-DE analysis. The present study revealed a subset of neuronal and/or glial proteins that appears to be deregulated in PD and likely to contribute to neurodegeneration. Observed alterations not only consolidate well accepted concepts surrounding PD pathogenesis such as oxidative stress and mitochondrial dysfunction but also point out to novel pathways. Among the latter, cytosolic non specific dipeptidase 2 (CNDP2), a relatively unknown protein not yet reported to be associated with PD pathogenesis, was shown to be increased in the SN of PD patients, as confirmed by Western blot. Immunohistochemical analyses demonstrated the presence of CNDP2 within the cytoplasm of SN dopaminergic neurons. Altogether, our findings support a key role of CNDP2 in PD neurodegeneration, by mechanisms that could involve oxidative stress, protein aggregation or inflammation. This article is part of a Special Issue entitled: Translational Proteomics.
authors.affiliation: Neuroproteomics Group, University Medical Center, Geneva, Switzerland.
authors.forename: Virginie
authors.initials: V
authors.lastname: Licker
authors.forename: Mélanie
authors.initials: M
authors.lastname: Côte
authors.forename: Johannes Alexander
authors.initials: JA
authors.lastname: Lobrinus
authors.forename: Neftali
authors.initials: N
authors.lastname: Rodrigo
authors.forename: Enikö
authors.initials: E
authors.lastname: Kövari
authors.forename: Denis F
authors.initials: DF
authors.lastname: Hochstrasser
authors.forename: Natacha
authors.initials: N
authors.lastname: Turck
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Sanchez
authors.forename: Pierre R
authors.initials: PR
authors.lastname: Burkhard
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004150:Dipeptidases / Q000096:biosynthesis*; D059290:Dopaminergic Neurons / Q000378:metabolism / Q000473:pathology; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D008297:Male; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009457:Neuroglia / Q000378:metabolism / Q000473:pathology; D018384:Oxidative Stress; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology; D020543:Proteome; D013378:Substantia Nigra / Q000378:metabolism* / Q000473:pathology
chemical_list: D009419:Nerve Tissue Proteins; D020543:Proteome; D004150:Dipeptidases; C031499:CNDP2 protein, human